Centre for Addiction and Mental Health

Does Psilocybin Change Synaptic Density in Amnestic Mild Cognitive Impairment

Phase 2Completed202310 people18 Sept 2023clinicaltrials.gov

NCT05744479

Phase 4Recruiting2023100 people27 Feb 2023clinicaltrials.gov

NCT05531591

Phase 4Completed201987 people8 Sept 2022clinicaltrials.gov

NCT03947827

Phase 3Completed202076 people13 May 2019clinicaltrials.gov

NCT03043443

Phase 2Completed201760 people6 Feb 2017clinicaltrials.gov

NCT03000387

Phase 4Completed2018211 people22 Dec 2016clinicaltrials.gov

NCT02439944

Phase 2/3Terminated201518 people12 May 2015clinicaltrials.gov

NCT02362529

Early phase 1Completed2015115 people13 Feb 2015clinicaltrials.gov

NCT02269540

Early phase 1Completed201410 people21 Oct 2014clinicaltrials.gov

NCT02167620

Phase 4Completed201435 people19 Jun 2014clinicaltrials.gov

NCT02108626

Phase 4Completed201443 people9 Apr 2014clinicaltrials.gov

NCT01934023

Phase 2Completed201324 people4 Sept 2013clinicaltrials.gov

NCT01850953

Phase 4Completed201328 people10 May 2013clinicaltrials.gov

NCT01286584

Phase 4Completed201133 people31 Jan 2011clinicaltrials.gov

NCT01093365

Phase 2Completed201058 people25 Mar 2010clinicaltrials.gov

NCT01023659

Phase 4Completed2010893 people2 Dec 2009clinicaltrials.gov

NCT01022229

CollaboratorPhase 3Completed201316 people1 Dec 2009clinicaltrials.gov

NCT01015170

Phase 4Completed2009454 people18 Nov 2009clinicaltrials.gov

NCT00704990

CollaboratorPhase 2/3Completed200828 people25 Jun 2008clinicaltrials.gov

NCT00183560

Phase 4Completed2004184 people16 Sept 2005clinicaltrials.gov